Medicine & TechnologyA groundbreaking research links human-derived growth hormone to a potential risk of Alzheimer's transmission. The study prompts a reevaluation of safety measures in medical procedures.
Discover how scientists can observe and control changes in Tau proteins linked to degenerative diseases. Read on to learn more about this breakthrough.
Researchers observe the presence higher levels of a certain protein among female brains with Alzheimer's compared to their male counterparts. Read to know more about these findings and their impact.
Researchers come up with a novel blood test that may detect Alzheimer's toxin even years before patients start exhibiting symptoms. Read to know more about these findings and their potential.
Researchers discover how swelling in neural axons is linked to the severity of Alzheimer's disease. Read to know more about these findings and their impact on what is known about Alzheimer's.
New AI system sifts through thousands of brain scans to identify patterns linked to mental disorders. Click here to know more about the complex program and how it can lead to early detection and treatment of diseases like Alzheimer's.
Scientists developed a new device, a lawyer-based diamond sensor that can detect disorders more accurately. Read and find out more about this new technology.
In a recent study, older adults suffering from mild cognitive impairment or dementia were able to enhance their memory through the use of a personal assistant application on their smartphones to get reminded about upcoming activities and events.
Researchers form the Gwangju Institute of Science and Technology, South Korea, have developed a non-invasive novel light technique that will allow clinicians to accurately measure the cerebral blood flow of patients for a more accurate brain health and diseases diagnosis.
In a world-first discovery, researchers have observed how blood oxygen levels in the brain affect memory loss, a precursor to the development of Alzheimer's disease.
Eli Lily published detailed reports on the efficacy of Phase 2 clinical trials of donanemab, supporting the controversial amyloid hypothesis. Experts believe it could revolutionize Alzheimer's therapies.
Researchers discovered that YKL-40 is both controlled by clock genes and engaged in clearing away, possibly toxic accumulation of 'Alzheimer's proteins in the brain.'